AMAT

The stock surged due to expanded EPIC Center partnerships, a Goldman Sachs tactical upgrade, and strong Q4 results from Micron.

The stock rose on Morgan Stanley's FY27 forecast raise, EPIC Center partnerships with KIOXIA and Besi, and strong Micron results.

The stock rallied after expanding strategic EPIC Center partnerships with Besi and KIOXIA, alongside pre-investor event positioning.

Morgan Stanley raised its 2027 forecast for AMAT and the company announced an R&D collaboration with KIOXIA Corporation.

The stock surged following a $5B India investment, Wall Street capex forecast hikes and upgrades, and a new etching product launch.

The stock surged due to a $5B India R&D investment, upgraded WFE spending forecasts, and a SEMICON West presentation announcement.

The stock jumped following a $5.0 billion India expansion plan, bullish analyst target upgrades, and a sector-wide chip stock rebound.

Shares surged following a $5B India expansion plan and an institutional capital rotation into chip equipment stocks.

The stock surged due to analyst upgrades and strong sector-wide AI tailwinds following its Q3 FY2026 earnings release.

AMAT dropped after earnings due to elevated buyside expectations, flat gross margin guidance, and valuation fatigue despite a beat-and-raise.

The stock rose on strong AI spend signals from Microsoft and Lam Research, along with relief from an overextended sell-off on China news.

AMAT fell due to a global chip sell-off triggered by SK Hynix capex caution, AI ROI skepticism, Chinese competition, and macro headwinds.

A report revealed a Chinese firm achieved mass production of domestic DUV lithography tools, threatening Western market share in China.

The stock dropped due to a sector-wide selloff triggered by TSMC capex concerns, Chinese DUV tool advances, and AI model cost fears.

The stock fell due to Michael Burry's short disclosure, an Asian chipmaker crash, and heavy insider stock sales by senior executives.

The stock dropped due to NAND oversupply fears, sector-wide AI profit-taking, executive insider selling, and geopolitical risks.

Reports that Meta plans to rent out surplus AI capacity sparked fears of CapEx deferrals, triggering sector-wide profit-taking.

The stock surged after AMAT unveiled new AI chipmaking tools and received multiple Wall Street price target upgrades.

KeyBanc raised its price target to $750 alongside a major AI DRAM product launch and Russell Top 50 Index inclusion.